Before buying, handling, or using any product, check whether it is legal in your location and consult a qualified medical professional
A reasonable harm reduction approach for people on cardiovascular medications includes informing healthcare providers about BPC-157 use, starting with conservative doses, monitoring blood pressure and other relevant parameters closely, watching for any changes in medication effectiveness, and being prepared to discontinue if unexpected effects emerge
Nutrition, movement, hydration, sleep, and provider guidance still matter, and will serve to greatly build upon the possible benefits
The FDA subsequently classified AOD-9604 within Category 2 of the bulk drug substance review process, and the compound was later withdrawn from that nomination in April 2026